Status:
COMPLETED
Transfusion Requirements in Cardiac Surgery
Lead Sponsor:
Nadine Shehata
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Health Canada
Conditions:
Cardiac Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a multi-centre randomized controlled pilot trial of two transfusion strategies in high risk patients having cardiac surgery. This study will be conducted in 7 Canadian centers and 1 American c...
Eligibility Criteria
Inclusion
- 18 years or older
- European System for Cardiac Operative Risk Evaluation (EuroSCORE) of 6 or more
- Consent
Exclusion
- Pregnancy
- Refusal of blood products
- Participating in autologous blood donation program
- Based on the preoperative hemoglobin, the predicted hematocrit on cardiopulmonary bypass is greater than 33% (hemoglobin concentration of 110 g/L) or less than 18% (hemoglobin concentration of 60 g/L)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2012
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT01484639
Start Date
January 1 2012
End Date
November 1 2012
Last Update
February 21 2013
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
2
Foothills Medical Centre
Calgary, Alberta, Canada, T2N 2T9
3
Alberta Health Services
Edmonton, Alberta, Canada, T6G2B7
4
St. Boniface General Hospital
Winnipeg, Manitoba, Canada, R2H 2A6